Volumetric gain of the liver after major hepatectomy in obese patients: A case-matched study in 84 patients

Annals of Surgery

Volumn 258, Issue 5, 2013, Pages 696-704

  Truant, Stéphanie ^a,b   Bouras, Ahmed Fouad ^a   Petrovai, Gheorghe ^a   Buob, David ^a   Ernst, Olivier ^a   Boleslawski, Emmanuel ^a   Hebbar, Mohamed ^b   Pruvot, François René ^a  

^a Department of Digestive Surgery and Transplantation ^*  (United States)

^b UNIV LILLE   (France)

Author keywords

Liver regeneration; Major hepatectomy; Obesity; Postoperative outcome; Volumetry

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLEEDING; BODY MASS; BODY WEIGHT; FEMALE; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER RESECTION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MAJOR HEPATECTOMY; MALE; MORBIDITY; MORTALITY; OBESITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STEATOSIS;

BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER DISEASES; LIVER REGENERATION; MALE; MIDDLE AGED; OBESITY; ORGAN SIZE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84886101352     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182a61a22     Document Type: Article

References (71)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346:1221-1231.
2. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012;82:1-8.
3. Branca F, Nikogosian H, Lobstein T. The Challenge of Obesity in the WHO European Region and the Strategies for Response. Copenhagen, Denmark: World Health Organization Regional Office for Europe; 2007.
4. Bailey MA, Brunt EM. Hepatocellular carcinoma: predisposing conditions and precursor lesions. Gastroenterol Clin North Am. 2002;31:641-662. (Pubitemid 34761230)
5. Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009;49:851-859.
6. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007;13:4199-4206. (Pubitemid 47377159)
7. Pathak S, Tang JM, Terlizzo M, et al. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol. 2010;36:52-57.
8. Vigano L, Kluger MD, Laurent A, et al. Liver resection in obese patients: results of a case-control study. HPB (Oxford). 2011;13:103-111.
9. Dindo D, Muller MK, Weber M, et al. Obesity in general elective surgery. Lancet. 2003;361:2032-2035. (Pubitemid 36695045)
10. Miles RH, Carballo RE, Prinz RA, et al. Laparoscopy: the preferred method of cholecystectomy in the morbidly obese. Surgery. 1992;112:818-822; discussion 822-823.
11. Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15:2164-2172.
12. Benoist S, Panis Y, Alves A, et al. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg. 2000;179:275-281. (Pubitemid 30394688)
13. Dhar DK, Kubota H, Tachibana M, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59:18-23. (Pubitemid 30435830)
14. Williams TK, Rosato EL, Kennedy EP, et al. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg. 2009;208:210-217.
15. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003;7:1034-1044. (Pubitemid 37524071)
16. Young AL, Wilson D, Ward J, et al. Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study. HPB (Oxford). 2012;14:194-200.
17. McCormack L, Petrowsky H, Jochum W, et al. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007;245:923-930. (Pubitemid 46809294)
18. Vetelainen R, van Vliet A, Gouma DJ, et al. Steatosis as a risk factor in liver surgery. Ann Surg. 2007;245:20-30. (Pubitemid 46035431)
19. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science. 1996;274:1185-1188. (Pubitemid 26389283)
20. Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389:374-377. (Pubitemid 27415217)
21. Balzan S, Nagarajan G, Farges O, et al. Safety of liver resections in obese and overweight patients. World J Surg. 2010;34:2960-2968.
22. Mathur AK, Ghaferi AA, Osborne NH, et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010;14:1285-1291.
23. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva, Switzerland: World Health Organization; 1997.
24. Millet G, Truant S, Leteurtre E, et al. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a casematched study in 82 patients. Ann Surg. 2012;256:755-761; discussion 761-762.
25. Dello SA, Stoot JH, van Stiphout RS, et al. Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy. World J Surg. 2011;35:386-392.
26. Couinaud C. Plea for exact hepatic segmentation and an anatomic technic of regular resection of the liver. Partial clamping of the hepatic stump. Presse Med. 1966;74:2849-2852.
27. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540-548.
28. Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or = 0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg. 2007;204:22-33. (Pubitemid 44960031)
29. Boleslawski E, Decanter G, Truant S, et al. Right hepatectomy with extrahepatic vascular division prior to transection: intention-to-treat analysis of a standardized policy. HPB (Oxford). 2012;14:688-699.
30. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
31. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202-1219. (Pubitemid 36538699)
32. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289-293. (Pubitemid 26260021)
33. Nadalin S, Testa G, Malago M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 2004;10:1024-1029. (Pubitemid 39232757)
34. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213. (Pubitemid 38963009)
35. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713-724.
36. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356-1362.
37. DeLand FH, North WA. Relationship between liver size and body size. Radiology. 1968;91:1195-1198.
38. Braillon A, Capron JP, Herve MA, et al. Liver in obesity. Gut. 1985;26: 133-139. (Pubitemid 15105138)
39. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119. (Pubitemid 40629025)
40. Kam I, Lynch S, Svanas G, et al. Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology. 1987;7:362-366. (Pubitemid 17062730)
41. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176:2-13.
42. Miyagawa S, Kawasaki S, Noike T, et al. Liver regeneration after extended right hemihepatectomy in patients with hilar or diffuse bile duct carcinoma. Hepatogastroenterology. 1999;46:364-368. (Pubitemid 29154778)
43. Van Thiel DH, Gavaler JS, Kam I, et al. Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology. 1987;93:1414-1419. (Pubitemid 17167287)
44. Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-298. (Pubitemid 128409616)
45. de Meijer VE, Kalish BT, Puder M, et al. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg. 2010;97:1331-1339.
46. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46. (Pubitemid 30439557)
47. Gomez D, Malik HZ, Bonney GK, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94:1395-1402. (Pubitemid 350144389)
48. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406; discussion 406-407.
49. Hakamada K, Sasaki M, Takahashi K, et al. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res. 1997;70:12-20. (Pubitemid 27300645)
50. Vetelainen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245:44-50. (Pubitemid 46035434)
51. Selzner M, Rudiger HA, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32: 1280-1288.
52. Rao MS, Papreddy K, Abecassis M, et al. Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci. 2001;46:1821-1826. (Pubitemid 32844146)
53. Cho JY, Suh KS, Kwon CH, et al. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery. 2006;139:508-515.
54. Cho JY, Suh KS, Kwon CH, et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl. 2005;11:210-217. (Pubitemid 40268219)
55. Nagai S, Fujimoto Y, Kamei H, et al. Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg. 2009;96:437-444.
56. McCormack L, Petrowsky H, Jochum W, et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246:940-946; discussion 946-948. (Pubitemid 350179176)
57. Sandhofer A, Laimer M, Ebenbichler CF, et al. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res. 2003;11:760-768. (Pubitemid 41151602)
58. Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83:1059-1066. (Pubitemid 28520935)
59. Chiarugi P, Fiaschi T. Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration. Expert Opin Ther Targets. 2010;14:193-206.
60. Harris RB. Leptin-much more than a satiety signal. Annu Rev Nutr. 2000;20:45-75.
61. Redaelli CA, Semela D, Carrick FE, et al. Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. J Hepatol. 2004;40:305-312. (Pubitemid 38115837)
62. Shirai M, Yamauchi H, Nakayama H, et al. Expression of epidermal growth factor receptor protein in the liver of db/db mice after partial hepatectomy. Exp Toxicol Pathol. 2007;59:157-162. (Pubitemid 350030446)
63. Pizarro M, Balasubramaniyan N, Solis N, et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut. 2004;53:1837-1843. (Pubitemid 39556907)
64. Foster GD, Wadden TA, Mullen JL, et al. Resting energy expenditure, body composition, and excess weight in the obese. Metabolism. 1988;37: 467-472.
65. Krenitsky J. Adjusted body weight, pro: evidence to support the use of adjusted body weight in calculating calorie requirements. Nutr Clin Pract. 2005;20: 468-473. (Pubitemid 47050816)
66. Hawn MT, Bian J, Leeth RR, et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg. 2005;241:821-826; discussion 826-828.
67. Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256:624-633.
68. Gedaly R, McHugh PP, Johnston TD, et al. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients. Ann Surg. 2009;249:414-419.
69. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85:1058-1060. (Pubitemid 28360766)
70. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-2072. (Pubitemid 46622116)
71. Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256:746-752; discussion 752-754.